Details
- Deadline
- Research Field
- Natural sciences
- Career Stage
- First Stage Researcher (R1) (Up to the point of PhD)
About
Outline
Genome-wide association studies (GWAS) have identified robust risk loci for Alzheimer’s disease (AD).
These findings serve as a starting point for novel biological investigation and treatment strategies, once such loci contains the transcription factor MEF2C.
This programme has a number of specific aims:
Identify the DNA targets of MEF2C genome-wide
Investigate the gene expression networks regulated by MEF2C isoforms
Define the MEF2C interactome
Test data driven hypotheses about the cellular function of MEF2C in microglia
What is funded
| Full UK/EU tuition fees |
| If applicable, any eligible non-home fee paying candidate must fund the remainder of the overseas fee themselves. |
| Doctoral stipend matching UK Research Council National Minimum |
Duration
3 Years
Eligibility
Open to all UK/EU students without further restrictions |
You will hold or expect to achieve a First or Upper Second Class degree in a relevant area (e.g. neuroscience, psychology, anatomy, physiology, natural sciences). As this is a training doctorate, previous research experience is not essential. |
Organisation
- Organisation name
- Cardiff University
- Organisation Country
- More Information
The responsibility for the funding offers published on this website, including the funding description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.